C.H. Robinson officer executes 10b5-1 sale; retains 130,591 shares
Rhea-AI Filing Summary
Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.
Positive
- Transaction executed under a documented 10b5-1 plan adopted 05/08/2025, indicating pre-planned trading and compliance with insider trading procedures
- Substantial remaining ownership of 130,591 shares, largely composed of restricted stock units and deferred shares, which supports ongoing alignment with shareholder interests
Negative
- Officer sold 2,500 shares on 08/15/2025 at $121.74 per share; while disclosed, the filing does not provide context on whether the sale affects compensation or diversification plans
Insights
TL;DR Insider sale of 2,500 shares under a 10b5-1 plan; substantial remaining ownership of 130,591 shares maintains alignment with shareholders.
The sale recorded on 08/15/2025 at $121.74 per share was executed under a documented 10b5-1 plan adopted 05/08/2025, which indicates pre-planned disposition rather than opportunistic trading. Post-transaction beneficial ownership of 130,591 shares includes a large portion held in restricted stock units and deferred compensation, suggesting continued long-term exposure to company equity. The transaction size (2,500 shares) is small relative to the reported total holdings and does not, by itself, indicate a material change in insider alignment.
TL;DR Use of a formal 10b5-1 plan and attorney-in-fact signature reflects procedural compliance and documentation of the insider trade.
The filing documents adoption of a 10b5-1(c) trading plan on 05/08/2025 and a transaction completed under that plan on 08/15/2025. The signature by an attorney-in-fact is consistent with delegated execution. The disclosure of amounts held in restricted stock units, deferred accounts, and ESPP shares provides transparent reporting of indirect and direct ownership. From a governance perspective these elements indicate adherence to standard insider trading controls and disclosure practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,500 | $121.74 | $304K |
Footnotes (1)
- Adoption date of referenced 10b5-1(c) plan is: 05-08-2025 Included in this amount are 91,210 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 38,994 shares held directly by the reporting person. Includes 387 shares acquired pursuant to the Issuer's employee stock purchase plan.
